Recently, Optum, a subsidiary of UnitedHealth Group, has come under the spotlight due to its acquisition of numerous physician practices. This has led to increased scrutiny from state regulators, particularly in Oregon, where the purchase has drawn significant attention. Despite its massive growth over the years, most of Optum’s acquisitions have gone relatively unnoticed by the public. However, as more states begin to implement stricter regulations on healthcare mergers and acquisitions, it is likely that we will see more scrutiny for deals in the future.
Oregon is leading the way in advocating for more oversight in healthcare mergers and acquisitions, with some of the most stringent health care market oversight laws in the country. Other states such as Illinois, Minnesota and New York have followed suit and approved similar programs. As a result, these states are now subjecting healthcare deals to increased scrutiny. In addition to these states, five others – Vermont, Washington, Pennsylvania, Indiana and New Mexico – are currently considering legislation to begin or expand their own oversight programs. This trend reflects a growing concern about the potential risks associated with large-scale healthcare industry mergers and acquisitions.